Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis

CD166 has been identified as an important cancer stem cell (CSC) marker in colorectal cancer (CRC). The purpose of our study was to investigate the relationship between CD166 expression and clinical features and to examine the role of CD166 expression on the survival of patients with CRC. A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Susu, Yang, Wei, Zong, Shaoqi, Li, Hongjia, Liu, Shanshan, Li, Wen, Shi, Qi, Hou, Fenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610009/
https://www.ncbi.nlm.nih.gov/pubmed/28969077
http://dx.doi.org/10.18632/oncotarget.17442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610009/
https://www.ncbi.nlm.nih.gov/pubmed/28969077
http://dx.doi.org/10.18632/oncotarget.17442

Ejemplares similares